Overview
Basal cell carcinoma (BCC) of the chest wall is a type of non-melanoma skin cancer arising from basal cells of the epidermis. It typically presents as a slowly growing, locally invasive lesion with minimal potential for metastasis but significant risk of local tissue destruction if left untreated. Commonly affecting sun-exposed areas, chest wall BCC can occur in individuals of any age but is more prevalent in middle-aged to elderly populations, particularly those with fair skin and a history of chronic sun exposure. Early detection and appropriate management are crucial to prevent extensive tissue damage and functional impairment. This matters in day-to-day practice as timely intervention can significantly improve outcomes and reduce the need for complex reconstructive procedures 16.Pathophysiology
Basal cell carcinoma arises from the basal cells of the epidermis, which are responsible for maintaining the skin barrier. The pathogenesis often involves mutations in genes such as PTCH1 and SMO, which are key components of the Hedgehog signaling pathway. These mutations disrupt normal cellular differentiation and proliferation, leading to uncontrolled growth of basal cells. The progression typically follows a stepwise model, starting with initiation through DNA damage (often induced by ultraviolet radiation), followed by promotion through chronic irritation or repeated trauma, and finally progression to invasive carcinoma. At the cellular level, this results in a hierarchy of changes including hyperproliferation, impaired apoptosis, and increased angiogenesis, facilitating tumor growth and local invasion 16.Epidemiology
Basal cell carcinoma is one of the most common malignancies worldwide, with varying incidence rates depending on geographic location and demographic factors. In regions with high sun exposure, such as parts of North America and Europe, the incidence is notably higher. While chest wall BCC is less common compared to BCCs on the face and neck, it still constitutes a significant proportion of chest wall malignancies. The disease predominantly affects older adults, with a slight male predominance observed in some studies. Risk factors include prolonged sun exposure, fair skin, and a history of previous skin cancers. Trends over time indicate an increasing incidence, likely due to increased awareness and detection rates, as well as environmental factors 16.Clinical Presentation
Chest wall BCC typically presents as a pearly, translucent nodule with telangiectatic vessels on its surface, often with a rolled border and central ulceration. Patients may report a slowly enlarging mass, bleeding, or pain, especially if the lesion invades deeper tissues. Atypical presentations can include infiltrative growth patterns that mimic other chest wall pathologies, such as chronic wounds or fibrotic scars. Red-flag features include rapid growth, ulceration, and signs of systemic involvement, which are rare but necessitate urgent evaluation to rule out more aggressive malignancies 16.Diagnosis
The diagnostic approach for chest wall BCC involves a thorough clinical examination, often supplemented by imaging studies such as MRI or CT scans to assess depth of invasion and involvement of underlying structures. Histopathological confirmation is essential and typically achieved through excisional biopsy or punch biopsy. Key diagnostic criteria include:Management
Surgical Excision
Adjuvant Therapies
Refractory Cases
Complications
Prognosis & Follow-up
The prognosis for chest wall BCC is generally favorable with appropriate treatment, with low rates of metastasis. Prognostic indicators include lesion size, depth of invasion, and adequacy of surgical margins. Recommended follow-up includes:Special Populations
Key Recommendations
References
1 Pachuau L, Wu XY, Fu ML, Cui XM, Chen XD. Surgical Treatment for Chest "Lock" Keloid Using Autologous Split-Thickness Skin Grafting and Postoperative Radiotherapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2023. link 2 Davison SP, Sobanko JF, Clemens MW. Use of a collagen-glycosaminoglycan copolymer (Integra) in combination with adjuvant treatments for reconstruction of severe chest keloids. Journal of drugs in dermatology : JDD 2010. link 3 Plásek J, Hosková B. Solvatochromic effect in the optical spectra of calcofluor and its relation to fluorescent staining of yeast cell walls. Journal of fluorescence 2010. link 4 Levinson JN, Shahinian S, Sdicu AM, Tessier DC, Bussey H. Functional, comparative and cell biological analysis of Saccharomyces cerevisiae Kre5p. Yeast (Chichester, England) 2002. link 5 Ram AF, Wolters A, Ten Hoopen R, Klis FM. A new approach for isolating cell wall mutants in Saccharomyces cerevisiae by screening for hypersensitivity to calcofluor white. Yeast (Chichester, England) 1994. link 6 Shiba E, Koyama H, Noguchi S, Miyauchi K, Kodama K, Doi O et al.. Reconstruction of the chest wall after full thickness resection: a comparison between myocutaneous flap and acrylic resin plate as reconstructive techniques. International surgery 1988. link 7 Roberts K, Hills GJ. The crystalline glycoprotein cell wall of the green alga Chlorogonium elongatum: a structural analysis. Journal of cell science 1976. link